Sanofi will initiate the development process called passaging, which will yield a working seed for the vaccine. Passaging is the process to acclimate virus to grow in a production environment at optimum yield. This process is expected to take approximately two weeks, said the company.
Wayne Pisano, President and CEO, Sanofi Pasteur, said: “Sanofi Pasteur looks forward to quickly understanding how this virus performs in a vaccine manufacturing environment and developing a working seed that will enable large-scale production. This is an important step for engaging Sanofi Pasteur’s resources and expertise to support public health authorities and the directives they provide us.